These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29102419)

  • 41. Decrease in Pneumococcal Otitis Media Cultures With Concomitant Increased Antibiotic Susceptibility in the Pneumococcal Conjugate Vaccines Era.
    Jabarin B; Pitaro J; Lazarovitch T; Gavriel H; Muallem-Kalmovich L; Eviatar E; Marom T
    Otol Neurotol; 2017 Jul; 38(6):853-859. PubMed ID: 28414696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pediatric otitis media in Japan: A nationwide longitudinal study of the pre- and post-pneumococcal conjugate vaccine eras born in 2001 and 2010.
    Uraguchi K; Matsumoto N; Mitsuhashi T; Takao S; Makihara S; Ando M; Yorifuji T
    Vaccine; 2024 Jul; 42(19):4081-4087. PubMed ID: 38760268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era.
    Wiese AD; Griffin MR; Zhu Y; Mitchel EF; Grijalva CG
    Vaccine; 2016 Dec; 34(50):6243-6249. PubMed ID: 27832918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years.
    Greenberg D; Givon-Lavi N; Ben-Shimol S; Ziv JB; Dagan R
    Vaccine; 2015 Aug; 33(36):4623-9. PubMed ID: 26116251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.
    De Wals P; Lefebvre B; Deceuninck G; Longtin J
    Vaccine; 2018 Jan; 36(3):421-426. PubMed ID: 29224962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. All-cause pneumonia hospitalizations in children <2 years old in sweden, 1998 to 2012: impact of pneumococcal conjugate vaccine introduction.
    Berglund A; Ekelund M; Fletcher MA; Nyman L
    PLoS One; 2014; 9(11):e112211. PubMed ID: 25379659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pneumococcal acute otitis media in infants and children in central Romania, 2009-2011: microbiological characteristics and potential coverage by pneumococcal conjugate vaccines.
    Falup-Pecurariu O; Leibovitz E; Mercas A; Bleotu L; Zavarache C; Porat N; Dagan R; Greenberg D
    Int J Infect Dis; 2013 Sep; 17(9):e702-6. PubMed ID: 23522635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 7-Valent pneumococcal conjugate vaccine and otitis media: effectiveness of a 2-dose versus 3-dose primary series.
    Stoecker C; Hampton LM; Moore MR
    Vaccine; 2012 Sep; 30(44):6256-62. PubMed ID: 22906725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.
    Cohen R; Levy C; Bingen E; Koskas M; Nave I; Varon E
    Pediatr Infect Dis J; 2012 Mar; 31(3):297-301. PubMed ID: 22330166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Nuorti JP; Whitney CG;
    MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance.
    Ben-Shimol S; Greenberg D; Givon-Lavi N; Schlesinger Y; Somekh E; Aviner S; Miron D; Dagan R
    Vaccine; 2014 Jun; 32(27):3452-9. PubMed ID: 24690148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative impact of pneumococcal conjugate vaccines on pneumococcal meningitis according to underlying conditions.
    Cohen R; Varon E; Béchet S; Bonacorsi S; Levy C
    Vaccine; 2016 Sep; 34(41):4850-4856. PubMed ID: 27595445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: a review of economic evaluations (2006-2014).
    Wu DB; Chaiyakunapruk N; Chong HY; Beutels P
    Vaccine; 2015 Mar; 33(14):1633-58. PubMed ID: 25681663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Direct and indirect effects of the 13-valent pneumococcal conjugate vaccine administered to infants and young children.
    Esposito S; Principi N;
    Future Microbiol; 2015; 10(10):1599-607. PubMed ID: 26439470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pneumococcal vaccination in children at risk of developing recurrent acute otitis media - a randomized study.
    Gisselsson-Solén M; Melhus A; Hermansson A
    Acta Paediatr; 2011 Oct; 100(10):1354-8. PubMed ID: 21517964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands.
    Strutton DR; Farkouh RA; Earnshaw SR; Hwang S; Theidel U; Kontodimas S; Klok R; Papanicolaou S
    J Infect; 2012 Jan; 64(1):54-67. PubMed ID: 22085813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trends in healthcare utilization and costs associated with acute otitis media in the United States during 2008-2014.
    Tong S; Amand C; Kieffer A; Kyaw MH
    BMC Health Serv Res; 2018 May; 18(1):318. PubMed ID: 29720156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and economic burden of acute otitis media caused by Streptococcus pneumoniae in European children, after widespread use of PCVs-A systematic literature review of published evidence.
    Ricci Conesa H; Skröder H; Norton N; Bencina G; Tsoumani E
    PLoS One; 2024; 19(4):e0297098. PubMed ID: 38564583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.